These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8995911

  • 1. A model for the study of experimentally induced temporomandibular arthritis in rats: the effect of human recombinant interleukin-1 alpha on neuropeptide-like immunoreactivity.
    Carleson J, Alstergren P, Appelgren A, Appelgren B, Kopp S, Theodorsson E, Lundeberg T.
    J Orofac Pain; 1996; 10(1):9-14. PubMed ID: 8995911
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special consideration to rheumatoid arthritis.
    Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E.
    J Orofac Pain; 1995; 9(3):215-25. PubMed ID: 8995921
    [Abstract] [Full Text] [Related]

  • 3. Effects of adjuvant on neuropeptide-like immunoreactivity in the temporomandibular joint and trigeminal ganglia.
    Carleson J, Bileviciute I, Theodorsson E, Appelgren B, Appelgren A, Yousef N, Kopp S, Lundeberg T.
    J Orofac Pain; 1997; 11(3):195-9. PubMed ID: 9610308
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroendocrine, immune, and local responses related to temporomandibular disorders.
    Kopp S.
    J Orofac Pain; 2001; 15(1):9-28. PubMed ID: 11889652
    [Abstract] [Full Text] [Related]

  • 6. A model for experimental induction of acute temporomandibular joint inflammation in rats: effects of substance P(SP) on neuropeptide-like immunoreactivity.
    Carleson J, Alstergren P, Appelgren A, Appelgren B, Kopp S, Theodorsson E, Lundeberg T.
    Life Sci; 1996; 59(15):1193-201. PubMed ID: 8845005
    [Abstract] [Full Text] [Related]

  • 7. Co-variation of neuropeptide Y, calcitonin gene-related peptide, substance P and neurokinin A in joint fluid from patients with temporomandibular joint arthritis.
    Alstergren P, Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E.
    Arch Oral Biol; 1995 Feb; 40(2):127-35. PubMed ID: 7540832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. A correlation with symptoms, signs and arthroscopic findings.
    Holmlund A, Ekblom A, Hansson P, Lind J, Lundeberg T, Theodorsson E.
    Int J Oral Maxillofac Surg; 1991 Aug; 20(4):228-31. PubMed ID: 1719105
    [Abstract] [Full Text] [Related]

  • 10. Substance P-associated increase of intra-articular temperature and pain threshold in the arthritic TMJ.
    Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E.
    J Orofac Pain; 1998 Aug; 12(2):101-7. PubMed ID: 9656887
    [Abstract] [Full Text] [Related]

  • 11. Neuropeptides in temporomandibular joints with rheumatoid arthritis: a clinical study.
    Appelgren A, Appelgren B, Eriksson S, Kopp S, Lundeberg T, Nylander M, Theodorsson E.
    Scand J Dent Res; 1991 Dec; 99(6):519-21. PubMed ID: 1722347
    [Abstract] [Full Text] [Related]

  • 12. A model for experimentally induced temperomandibular joint arthritis in rats: effects of carrageenan on neuropeptide-like immunoreactivity.
    Lundeberg T, Alstergren P, Appelgren A, Appelgren B, Carleson J, Kopp S, Theodorsson E.
    Neuropeptides; 1996 Feb; 30(1):37-41. PubMed ID: 8868297
    [Abstract] [Full Text] [Related]

  • 13. Temporal changes in inflammatory mediator concentrations in an adjuvant model of temporomandibular joint inflammation.
    Spears R, Dees LA, Sapozhnikov M, Bellinger LL, Hutchins B.
    J Orofac Pain; 2005 Feb; 19(1):34-40. PubMed ID: 15779537
    [Abstract] [Full Text] [Related]

  • 14. The effect of a single intraperitoneal dose of hrIL-1 alpha on substance P-, neurokinin A-, calcitonin gene-related peptide- and neuropeptide Y-like immunoreactivity in cerebrospinal fluid, plasma and knee joint synovial fluid in the rat.
    Bileviciute I, Lundeberg T, Ekblom A, Theodorsson E.
    Regul Pept; 1994 Aug 31; 53(1):71-6. PubMed ID: 7528438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attenuation of pro-inflammatory neuropeptide levels produced by a cyclooxygenase-2 inhibitor in an animal model of chronic temporomandibular joint inflammation.
    Hutchins B, Patel H, Spears R.
    J Orofac Pain; 2002 Aug 31; 16(4):312-6. PubMed ID: 12455432
    [Abstract] [Full Text] [Related]

  • 18. Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp.
    Caviedes-Bucheli J, Lombana N, Azuero-Holguín MM, Munoz HR.
    Int Endod J; 2006 May 31; 39(5):394-400. PubMed ID: 16640639
    [Abstract] [Full Text] [Related]

  • 19. An experimental study of the neurogenic and the immunological contribution to "tennis elbow" in rats.
    Haker E, Theodorsson E, Lundeberg T.
    Inflammation; 1997 Feb 31; 21(1):35-44. PubMed ID: 9179620
    [Abstract] [Full Text] [Related]

  • 20. Capsaicin application to the temporomandibular joint alters calcitonin gene-related peptide levels in the trigeminal ganglion of the rat.
    Spears R, Hutchins B, Hinton RJ.
    J Orofac Pain; 1998 Feb 31; 12(2):108-15. PubMed ID: 9656888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.